Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07172789

Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5)

Head dOwn Position Before Endovascular Treatment for Large veSsel Occlusion (HOPES5): a Prospective, Randomized, Open Label, Blinded-end Point, Multi-center Study

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
210 (estimated)
Sponsor
General Hospital of Shenyang Military Region · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Recent studies suggest that head-down positioning (HDP) intervention may improve outcomes in ischemic stroke. In the era of reperfusion therapy, a key protective strategy is to administer neuroprotective interventions before recanalization to reduce the loss of the ischemic penumbra, thereby salvaging more penumbral tissue after revascularization and ultimately improving clinical outcomes. Based on this concept, and considering the neuroprotective effects of HDP, the investigators hypothesize that HDP intervention prior to endovascular therapy (EVT) in patients with large vessel occlusion could improve clinical outcomes. This hypothesis is further supported by a recent clinical study (NCT03728738), which demonstrated that compared to a sitting up position (30°), a flat supine position (0°) before EVT significantly reduced the incidence of neurological deterioration prior to the procedure. Building on the above rationale, this trial aims to investigate the efficacy and safety of HDP intervention prior to EVT in patients with large vessel occlusion.

Conditions

Interventions

TypeNameDescription
OTHERhead down positionthe patient is positioned at a -20° Trendelenburg

Timeline

Start date
2025-09-02
Primary completion
2026-09-30
Completion
2026-09-30
First posted
2025-09-15
Last updated
2025-09-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07172789. Inclusion in this directory is not an endorsement.